Welcome to Dr. Elliott Antman's AHA Emerging Science™ Series.
 

AHA is proud to introduce a new program to further science collaboration hosted by Dr. Elliot Antman: The AHA Emerging Science™ Series webinars are one hour professional quality webinars held three times per year. Dr. Antman will host each webinar, which will have two 30 minute blocks, consisting of presentations of original research from the following categories:

std_Portrait%20Antman11.jpg
  • Late Breaking Clinical Trials
  • Clinical Trial Updates of previously presented LBCTs
  • Late Breaking Basic Science
  • Major Bench-to-Bedside Advances
  • Major Conference Proceedings
  • Major Guidelines/Policy Statements

The live webinar events will be viewable from a computer or mobile phone, both live and on-demand. Attendees can ask questions electronically during the live event or post event. 

Join us at the next event, or view for past events by visiting the Emerging Science Series page on Professional Heart Daily.

ESS 2012: New Antithrombotic Therapies - Crossing Vascular Beds And Reversing Their Effects

08756b84378955ce8353f258a4ec1ecf-huge-la


New Antithrombotic Therapies - Crossing Vascular Beds and Reversing Their Effects
Presented: Wednesday, June 20, 2012
Presentation Topics:
 
       Vorapaxar for Secondary Prevention in Patients with Peripheral Artery Disease: Results from the Peripheral Artery Disease Cohort of the TRA 2°P-TIMI 50 Trial  
Presenter: Marc P. Bonaca, Brigham and Women's Hospital, Boston, Mass.
News Release  |  Abstracts in Circulation
   
  Reversal of Apixaban-Induced Alterations of Hemostasis By Different Coagulation Factor Concentrates: Studies In Vitro With Circulating Human Blood
Presenter: Gines Escolar, Department of
Hemotherapy and Hemostasis, Hospital Clinic, Barcelona, Spain
 News Release  |  Abstracts in Circulation
 
Moderators: 
  • Elliott Antman 
  • Robert Bonow
Panelists:
  • Alan Hirsch 
  • Cynthia Rutherford
  • Neil Zakai           
Posted by Alyson PON Editor on Jul 6, 2012 10:55 AM America/Chicago

Leave a Comment


Log in to post a comment.

Login or Join

Login or Join to post a comment.